Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1053/j.semvascsurg.2021.04.001 http://scihub22266oqcxt.onion/10.1053/j.semvascsurg.2021.04.001 34144744!8137351!34144744     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34144744&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Semin+Vasc+Surg 2021 ; 34 (2): 28-36 Nephropedia Template TP {{tp|p=34144744|t=2021. The impact of COVID-19 pandemic on vascular registries and clinical trials |pdf=|usr=}}{{34144744}} gab.com Text The impact of COVID-19 pandemic on vascular registries and clinical trials JO: Semin Vasc Surg http://www.kidney.de/pget.php?&tw=1&pmid=34144744 #FOAvip Quality improvement programs and clinical trial research experienced disruption due to the coronavirus disease 2019 (COVID-19) pandemic. Vascular registries showed an immediate impact with significant declines in second-quarter vascular procedure volumes witnessed across Europe and the United States. To better understand the magnitude and impact of the pandemic, organizations and study groups sent grass roots surveys to vascular specialists for needs assessment. Several vascular registries responded quickly by insertion of COVID-19 variables into their data collection forms. More than 80% of clinical trials have been reported delayed or not started due to factors that included loss of enrollment from patient concerns or mandated institutional shutdowns, weighing the risk of trial participation on patient safety. Preliminary data of patients undergoing vascular surgery with active COVID-19 infection show inferior outcomes (morbidity) and increased mortality. Disease-specific vascular surgery study collaboratives about COVID-19 were created for the desire to study the disease in a more focused manner than possible through registry outcomes. This review describes the pandemic effect on multiple VASCUNET registries including Germany (GermanVasc), Sweden (SwedVasc), United Kingdom (UK National Vascular Registry), Australia and New Zealand (bi-national Australasian Vascular Audit), as well as the United States (Society for Vascular Surgery Vascular Quality Initiative). We will highlight the continued collaboration of VASCUNET with the Vascular Quality Initiative in the International Consortium of Vascular Registries as part of the Medical Device Epidemiology Network coordinated registry network. Vascular registries must remain flexible and responsive to new and future real-world problems affecting vascular patients. Twit Text FOAVip The impact of COVID-19 pandemic on vascular registries and clinical trials ????Semin Vasc Surg http://www.kidney.de/pget.php?&tw=1&pmid=34144744 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34144744 #FOAvip English Wikipedia <ref>{{Cite pmid|34144744}}</ref> The impact of COVID-19 pandemic on vascular registries and clinical trials #MMPMID34144744 Aziz F; Behrendt CA; Sullivan K; Beck AW; Beiles CB; Boyle JR; Mani K; Benson RA; Wohlauer MV; Khashram M; Jorgensen JE; Lemmon GW Semin Vasc Surg 2021[Jun]; 34 (2): 28-36 PMID34144744show ga Quality improvement programs and clinical trial research experienced disruption due to the coronavirus disease 2019 (COVID-19) pandemic. Vascular registries showed an immediate impact with significant declines in second-quarter vascular procedure volumes witnessed across Europe and the United States. To better understand the magnitude and impact of the pandemic, organizations and study groups sent grass roots surveys to vascular specialists for needs assessment. Several vascular registries responded quickly by insertion of COVID-19 variables into their data collection forms. More than 80% of clinical trials have been reported delayed or not started due to factors that included loss of enrollment from patient concerns or mandated institutional shutdowns, weighing the risk of trial participation on patient safety. Preliminary data of patients undergoing vascular surgery with active COVID-19 infection show inferior outcomes (morbidity) and increased mortality. Disease-specific vascular surgery study collaboratives about COVID-19 were created for the desire to study the disease in a more focused manner than possible through registry outcomes. This review describes the pandemic effect on multiple VASCUNET registries including Germany (GermanVasc), Sweden (SwedVasc), United Kingdom (UK National Vascular Registry), Australia and New Zealand (bi-national Australasian Vascular Audit), as well as the United States (Society for Vascular Surgery Vascular Quality Initiative). We will highlight the continued collaboration of VASCUNET with the Vascular Quality Initiative in the International Consortium of Vascular Registries as part of the Medical Device Epidemiology Network coordinated registry network. Vascular registries must remain flexible and responsive to new and future real-world problems affecting vascular patients. |*Registries[MESH] |Biomedical Research/*statistics & numerical data[MESH] |COVID-19/*epidemiology/prevention & control/transmission[MESH] |Clinical Trials as Topic[MESH] |Humans[MESH] |Procedures and Techniques Utilization[MESH] |Quality Improvement[MESH]The impact of COVID-19 pandemic on vascular registries and clinical tr(epmc).pdf DeepDyve Pubget Overpricing